Unknown PHASE4 INTERVENTIONAL 2-arm NCT01535768

Effect of Prophylactic Aqueous Suppression on Hyperencapsulation of Ahmed Glaucoma Valves

Sponsor: Canadian Glaucoma Clinical Research Council

Conditions Glaucoma

Interventions Aqueous Suppressant Eye Drops

Updated 8 times since 2017 Last updated: Jul 19, 2017 Started: Feb 29, 2012 Primary completion: Jun 30, 2018 Completion: Jun 30, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01535768, this PHASE4 trial focuses on Glaucoma and remains ongoing. Sponsored by Canadian Glaucoma Clinical Research Council, it has been updated 8 times since 2012, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE4
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE4

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE4
Jul 2020 — Jan 2021 [monthly]

Unknown Status PHASE4

Status: Recruiting → Unknown Status
Jun 2018 — Jul 2020 [monthly]

Recruiting PHASE4

▶ Show 3 earlier versions

Aug 2017 — Jun 2018 [monthly]

Recruiting PHASE4
Feb 2017 — Aug 2017 [monthly]

Recruiting PHASE4
Jan 2017 — Feb 2017 [monthly]

Recruiting PHASE4

First recorded

Feb 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Canadian Glaucoma Clinical Research Council
Credit Valley EyeCare

Data source: Credit Valley EyeCare

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Mississauga, Canada